Longitudinal changes in BMI and an index estimating excess lipid among white and black adults in the USA


A recent meta-analysis by Nissen and Wolski [1] has raised serious concerns and generated considerable debate regarding the cardiovascular safety of rosiglitazone, a thiazolidinedione that is approved for treatment of hyperglycemia in people with diabetes. This meta-analysis suggested that rosiglitazone increased the risk of myocardial infarction by 43% and… (More)


  • Blog articles referencing this paper

  • Presentations referencing similar topics